220 related articles for article (PubMed ID: 6994763)
1. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
Manhem P; Hökfelt B
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
[No Abstract] [Full Text] [Related]
2. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
[TBL] [Abstract][Full Text] [Related]
3. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
Schoeppe W; Brecht HM
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
[TBL] [Abstract][Full Text] [Related]
4. An ambulatory trial of guanfacine.
Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.
Jerie P
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):157S-164S. PubMed ID: 6994770
[No Abstract] [Full Text] [Related]
6. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
Lauro R; Reda G; Spallone L; Anguissola AB
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
[No Abstract] [Full Text] [Related]
8. Effects of guanfacine monotherapy on blood pressure, heart rate, plasma renin activity, aldosterone, and catecholamines in hypertensive patients with chronic glomerulonephritis.
Ikeda T; Gomi T; Yuhara M; Sakurai J; Nakayama D
Clin Pharmacol Ther; 1988 Mar; 43(3):278-82. PubMed ID: 3278821
[TBL] [Abstract][Full Text] [Related]
9. Guanfacine: effects of long-term treatment and withdrawal.
Reid JL; Zamboulis C; Hamilton CA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
[TBL] [Abstract][Full Text] [Related]
10. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
Sorkin EM; Heel RC
Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of long-term treatment of essential hypertension with guanfacine.
Higuchi M; Overlack A; Stumpe KO
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):61S-64S. PubMed ID: 6994780
[TBL] [Abstract][Full Text] [Related]
12. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
[TBL] [Abstract][Full Text] [Related]
13. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
14. Relationships between blood pressure, heart rate and plasma epinephrine, norepinephrine, angiotensin II concentrations, plasma renin activity during chronic guanfacine therapy in patients with essential arterial hypertension.
Collart F; Staroukine M; Verniory A
Acta Cardiol; 1985; 40(3):269-76. PubMed ID: 3895792
[TBL] [Abstract][Full Text] [Related]
15. [Blood pressure and renin under treatment of hypertension with guanfacine (author's transl)].
Rosenthal J; Jäger H
MMW Munch Med Wochenschr; 1980 Jan; 122(4):137-40. PubMed ID: 6767938
[TBL] [Abstract][Full Text] [Related]
16. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
17. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
Barber ND; Reid JL
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
19. The effects of treatment and of withdrawal of treatment with guanfacine and clonidine on blood pressure and heart rate in normotensive and renal hypertensive rats.
Salzmann R
J Pharm Pharmacol; 1979 Apr; 31(4):212-6. PubMed ID: 36458
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamics in hypertensive patients before and during guanfacine treatment.
Schäfer N; Rauh J; Rosenthal J
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
